These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Determinants of antipsychotic selection and response include parameters of the primary
disorder, psychiatric and physical comorbidities, past treatment effects, patient preferences …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

Background Weight gain is common for people with schizophrenia and this has serious
implications for health and well being. Objectives To determine the effects of both …

Background Weight gain is common for people with schizophrenia and this has serious
implications for a patient's health and well being. Switching strategies have been …

Optimal clinical management of schizophrenia and bipolar disorder can be achieved
through careful antipsychotic dosing and, if necessary, switching to another well-chosen …

With the widespread use of atypical or second-generation antipsychotics, switching
treatment has become current practice and more complicated, as the pharmacological …

Introduction: In this review, the authors discuss the role of long-acting injectable
antipsychotics (LAIs) for schizophrenia, focusing on the effectiveness and new perspectives …

Introduction: Meta-analyses are a convenient way for clinicians and researchers to review
data regarding different interventions. Meta-analyses can overcome many of the limitations …

PURPOSE: Previous analysis of data from CATIE showed that patients randomly assigned
to switch to a new medication were more likely to discontinue study drug than those who …